Table 3 |
|||||
|
LAI data. |
|||||
|
Group |
Baseline |
4 weeks |
8 weeks |
Δ 0–4 wks |
Δ 0–8 wks |
|
|
|||||
|
OP |
12.4 ± 1.3 |
11.7 ± 1.7 |
11.8 ± 1.5 |
-0.7 ± 1.6 |
-0.6 ± 1.7 |
|
|
|||||
|
OT |
11.7 ± 1.5 |
8.2 ± 2.7 |
6.3 ± 2.3 |
-3.5 ± 2.2* |
-5.4 ± 2.2* |
|
|
|||||
|
|
|||||
|
NP |
11.7 ± 2.4 |
10.3 ± 1.5 |
9.9 ± 0.9 |
-1.4 ± 2.8* |
-1.9 ± 2.1* |
|
|
|||||
|
NT |
11.4 ± 1.2 |
7.6 ± 1.9 |
7.7 ± 1.4 |
-3.7 ± 2.1* |
-3.7 ± 1.7* |
|
|
|||||
|
Values at baseline, 4 weeks and 8 weeks are listed as means ± standard deviation. Mean changes (Δ) ± standard deviation after 4 weeks and 8 weeks compared to baseline are listed in the last two columns. A negative value indicates a decrease in value. Values* are significant comparisons (<0.05) based on analysis of variance model results comparing changes from baseline to 4 weeks or 8 weeks. Groups are as follows: OP = overweight/placebo, OT = overweight/treatment, NP = normal weight/placebo and NT = normal weight/treatment. |
|||||
|
Oben et al. Nutrition Journal 2009 8:38 doi:10.1186/1475-2891-8-38 |
|||||